Orthostatic intolerance in adolescent CFS
In 1999, James Stewart and colleagues at New York Medical College published a study in Pediatrics that connected two bodies of literature the medical community had been treating as unrelated: chronic fatigue syndrome and orthostatic intolerance. The paper documented that adolescents with CFS showed cardiovascular response patterns during orthostatic challenge that were consistent with dysautonomia — patterns matching those seen in established orthostatic intolerance conditions. This was among the first formal demonstrations that ME/CFS in a young population is not simply a fatigue disorder but is measurably tied to how the cardiovascular system handles the gravitational challenge of being upright. The clinical field has known this since 1999. For many patients, it has yet to reach the clinic.
The Study: Orthostatic Challenge in Adolescent CFS
Stewart and colleagues recruited adolescents with chronic fatigue syndrome and healthy age- and sex-matched controls and subjected both groups to orthostatic challenge — tilt table testing or the equivalent provocative maneuver that assesses how the cardiovascular system responds to upright posture. Heart rate and blood pressure responses were tracked throughout. The CFS patients showed patterns consistent with orthostatic tachycardia, with some displaying the excessive heart rate elevation on assuming upright posture that would later be formalized as the defining feature of POTS in the 1999 consensus criteria published the same year.
The significance of this finding in 1999 was that it placed CFS on the same physiological map as known cardiovascular reflex disorders. Prior to this line of work, CFS was evaluated primarily through symptom assessment and fatigue scales. The idea that upright posture was creating measurable cardiovascular stress in these patients — stress that differed objectively from what healthy controls showed — was a different framing entirely. The symptom of fatigue had a physiological correlate that could be observed, measured, and in principle addressed.
The Mechanism: Why Upright Posture Stresses the ME/CFS Cardiovascular System
The mechanism connecting CFS to orthostatic intolerance is the same pathway documented in adult POTS populations. When a person stands or sits upright, gravitational forces pool blood in the lower extremities and abdomen, reducing venous return to the heart. In a well-regulated cardiovascular system, this triggers a coordinated response: baroreflex-mediated vasoconstriction in peripheral vessels, mild heart rate increase, and activation of the renin-angiotensin-aldosterone axis to maintain blood pressure and cardiac output. The system compensates, and the brain receives adequate perfusion.
In adolescents with CFS, this compensation is insufficient. The tachycardia that appears during orthostatic challenge is not a primary problem — it is the cardiovascular system escalating heart rate in an attempt to maintain the cardiac output that would otherwise fall when venous return drops. The escalation is compensatory. What it is compensating for is the failure of other regulatory mechanisms to adequately manage the orthostatic load. The result is the same physiology that defines POTS: excessive tachycardia as the body tries to keep blood moving to the brain under conditions its regulatory systems cannot fully stabilize.
The connection to symptoms is direct. When upright posture chronically reduces effective cerebral perfusion — or forces the cardiovascular system into a state of high-demand, inadequate compensation — the results are fatigue, cognitive impairment, difficulty concentrating, and post-exertional worsening after activity. These are the cardinal symptoms of ME/CFS. They are also the cardinal symptoms of orthostatic intolerance. The 1999 paper was an early indicator that they may, in many patients, have the same mechanistic root.
The Diagnostic Boundary Problem
One of the enduring problems the Stewart 1999 paper highlights — not by design but by implication — is the diagnostic threshold problem. POTS is defined by a heart rate increase of 30 bpm or more in adults (40 bpm in adolescents under 19) within 10 minutes of standing, in the absence of orthostatic hypotension. Patients who fall just below this threshold — who show 25 bpm of orthostatic tachycardia, or who show elevated tachycardia at 15 minutes rather than 10, or who show it variably — are not captured by the POTS diagnosis. They receive no diagnosis for their orthostatic physiology.
For adolescents with ME/CFS whose orthostatic intolerance falls below formal POTS diagnostic criteria, the clinical result is an evaluation that finds "no significant orthostatic tachycardia" and clears them as normal. The physiology is present. The symptoms are driven by it. The number on the tilt table fell just short of the cutoff. This population — sub-threshold orthostatic intolerance in ME/CFS — has been known to exist since at least 1999, and remains systematically under-diagnosed and under-treated today.
What Standard ME/CFS Evaluation Misses
Standard evaluation for adolescents presenting with chronic fatigue typically involves blood work, assessment for sleep disorders, psychological evaluation, and in better-resourced settings a brief stand test or tilt table protocol. The tilt protocol, when it is performed, usually measures heart rate and blood pressure. This is an incomplete assessment of orthostatic physiology, for reasons the Stewart research highlights and that subsequent work has extended substantially.
Heart rate and blood pressure during a tilt test do not capture cerebral blood flow. Van Campen and Rowe's 2020 research established that severe ME/CFS patients can show cerebral blood flow reductions of nearly 25% from sitting alone, with normal heart rate and blood pressure throughout. Heart rate variability analysis — which would reveal the elevated resting sympathetic tone that Wyller and colleagues documented in adolescent ME/CFS — is not part of standard tilt protocols. The anticipatory autonomic activation that Wyller's group found with motor imagery would never be detected in a standard clinical assessment.
The gap between what the 1999 Stewart paper showed was possible to measure and what standard clinical evaluation actually measures has persisted for over two decades. Adolescents with ME/CFS are still being evaluated with tools that cannot detect the orthostatic physiology driving their symptoms, and being discharged as normal.
The Bridge Between ME/CFS and Dysautonomia Research
The Stewart 1999 paper is important as a historical marker for when the connection between ME/CFS and autonomic dysfunction was formally established in the literature. What followed it over the next quarter century — the work by van Campen, Wyller, Rowe, and others documenting cerebral blood flow deficits, autonomic dysregulation at rest, and the limitations of standard evaluation protocols — built on the foundation it laid. ME/CFS is not a fatigue disorder that incidentally involves some orthostatic symptoms. It is, in substantial measure, a condition in which the cardiovascular and autonomic systems cannot adequately regulate perfusion under the gravitational demands of daily life.
The implication for evaluation is direct: any adolescent presenting with ME/CFS should receive a thorough orthostatic assessment that goes beyond brief vital sign monitoring. The presence of orthostatic physiology changes what treatments are rational, what activities are sustainable, and what the mechanism of impairment actually is. Missing it means treating symptoms while leaving the driver in place. The clinical infrastructure to detect this physiology has existed since at least 1999. The question that the Stewart paper implicitly asks — 26 years later, still unanswered at the level of standard care — is when it will routinely be used.